Daiichi Sankyo sales and marketing update

Daiichi's Daiichi Sankyo UK unit launched Sevikar HCT in the U.K. to manage hypertension. The fixed-dose combination of olmesartan, an angiotensin II receptor blocker, amlodipine, a dihydropyridine ...